Skip to content

Gene Expression Profiles in Chronic Periodontitis

Gene Expression Profiles in Chronic Periodontitis: A Gene Network-based Microarray Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02467283
Enrollment
46
Registered
2015-06-10
Start date
2013-02-28
Completion date
2017-05-31
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Keywords

chronic periodontitis, genetics, microarray analysis, gingiva, genes, inflammation

Brief summary

Current concepts of the causes of periodontitis implicate a bacterial infection as the primary cause of the disease. Several bacterial species residing in a biofilm on tooth surfaces are closely associated with periodontitis. Chronic periodontitis (CP) is initiated and sustained by bacterial plaque, but host defense mechanisms play an integral role in its pathogenesis. Gene expression profiling is a powerful means of generating comprehensive genome-level data sets on diseases such as cancer, asthma, rheumatoid disorders and periodontitis, and provides significant insight information for these diseases. Gene expression profiling may provide an evidence for involving genes in the pathogenesis of CP and generate further information other than clinical signs and symptoms of CP. The aim of this study was to identify gene-expression patterns of patients with chronic periodontitis by whole-transcriptome gene-expression analyses.

Interventions

GENETICGenom-based whole-genome transcriptomic

Gene expression profiling is a powerful means of generating comprehensive genome-level data sets.

Sponsors

Kocaeli University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. CP patients had at least 20 teeth exhibiting \>30% of measured sites with \>5mm clinical attachment loss. 2. Had bleeding on probing (BOP) at \>50% of the proximal sites.

Exclusion criteria

1. Had any known systemic diseases that can influence the periodontal status, oral diseases other than chronic periodontitis and ongoing orthodontic therapy. 2. History of hepatitis, HIV infection, or diabetes; requirement for antibiotic prophylaxis, pregnancy or lactation; and long-term use of anti-inflammatory drugs. 3. Should be free of systemic diseases 4. Individuals had to be older than 18 years of age.

Design outcomes

Primary

MeasureTime frame
mRNA quantification2 months

Secondary

MeasureTime frame
Gen networking map2 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026